News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Amol Akhade: Common Drug Interactions with Abiraterone and Enzalutamide
Amol Akhade/hiranandanihospital.org
Jun 14, 2025, 13:51

Amol Akhade: Common Drug Interactions with Abiraterone and Enzalutamide

Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared a post on X:

“When you treat metastatic CRPC in elderly person, polypharmacy and drug to drug interactions needs to noted .
These are some common drug interactions with Abiraterone and Enzalutamide.
Useful for clinical practice.”

Amol Akhade: Common Drug Interactions with Abiraterone and Enzalutamide

More posts featuring Abiraterone.

abiraterone Amol Akhade cancer CRPC Enzalutamide OncoDaily Oncology prostate cancer
Special Coverage
Blog
Jul 19, 2025, 02:39
Alisher Kakharov: Training at the Prestigious Saint-Louis Hospital in Paris
Blog
Jul 19, 2025, 02:07
Bernard A. Fox: Back in Taiwan - Sharing the Next Frontier in Cancer Immunotherapy at Grand Rounds
Blog
Jul 19, 2025, 02:00
Akash Maniam: How Best to De-Escalate Excellent Responders and Intensify Those Who Don't
Insight
Jul 18, 2025, 21:36
Major disparities in access to Molecular Tumour Boards - Lung Cancer Europe
Oncolibrary
Jul 18, 2025, 21:35
Top 5 AI Tools for Medical Oncologists
Blog
Jul 18, 2025, 20:11
From Lab to Stage: Mastering Research Presentations as a PhD student - Manchester Cancer Research Centre
Blog
Jul 18, 2025, 19:49
Final Call for Discounted Registration to IASLC 2025 World Conference on Lung Cancer
Science
Jul 18, 2025, 19:26
Alfredo Addeo: A True Game Changer in Targeted Therapy for Lung Cancer
Blog
Jul 18, 2025, 19:23
Above and Beyond Awards ceremony at The Institute of Cancer Research
Blog
Jul 18, 2025, 19:04
"Belantamab Mafodotin Gives Patients a Chance," Says Diane Moran - International Myeloma Foundation
Insight
Jul 18, 2025, 18:53
Raffaele Colombo: International Nonproprietary Names Proposed List 133 Is Out
Insight
Jul 18, 2025, 18:46
Akhil Santhosh: OrigAMI1 - The Effect of Amivantamab in Previously Treated RAS Wild Colon Cancer